{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:38:02Z","timestamp":1763386682888,"version":"3.45.0"},"reference-count":81,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Extra-intestinal manifestations (EIMs) commonly occur in patients with inflammatory bowel diseases (IBD) and contribute significantly to morbidity and reduced quality of life. Their management remains challenging. Recently, the development of Janus Kinase (JAK) inhibitors has expanded the therapeutic options of luminal IBD, and three JAK inhibitors, tofacitinib, upadacitinib, and filgotinib, have been approved for IBD treatment, while a growing body of evidence suggests that JAK inhibitors may be a promising therapeutic option for the management of EIMs, particularly those affecting the joints and skin. In this comprehensive review, we aim to provide the available evidence concerning the impact of JAK inhibitors on EIMs treatment and analyze their underlying mechanisms of action.<\/jats:p>","DOI":"10.1177\/17562848251393391","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:06:52Z","timestamp":1763143612000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-8100","authenticated-orcid":false,"given":"Fotios S.","family":"Fousekis","sequence":"first","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Ulmenweg 18, Erlangen 91054, Germany"},{"name":"Division of Gastroenterology, Department of Internal Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece"},{"name":"Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Jefremow","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos H.","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8433","authenticated-orcid":false,"given":"Raja","family":"Atreya","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.117"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.042"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0091-9"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad108"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199607000-00009"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00128"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1089099"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212728"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211005708"},{"issue":"3","key":"e_1_3_5_11_2","article-title":"The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis","volume":"2","author":"Bao L","year":"2013","unstructured":"Bao L, Zhang H, Chan LS. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT 2013; 2(3): e24137.","journal-title":"JAKSTAT"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx158"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.11.025"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190405141410"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1226"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.738481"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm401490p"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0835-9"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219601"},{"key":"e_1_3_5_22_2","first-page":"97","article-title":"Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives","volume":"9","author":"Ly K","year":"2019","unstructured":"Ly K, Beck KM, Smith MP, et al. Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. Psoriasis (Auckl) 2019; 9: 97\u2013107.","journal-title":"Psoriasis (Auckl)"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01255-1"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_81_18"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620950093"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.33878\/2073-7556-2019-18-4-86-99"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab076.579"},{"key":"e_1_3_5_29_2","article-title":"Prospective observational study of tofacitinib in ulcerative colitis\u2014analysis of clinical data, fatigue and health-related quality of life during the induction phase","volume":"18","author":"Nyberg L","year":"2025","unstructured":"Nyberg L, Halfvarson J, Soderling J, et al. Prospective observational study of tofacitinib in ulcerative colitis\u2014analysis of clinical data, fatigue and health-related quality of life during the induction phase. Therap Adv Gastroenterol 2025; 18: 17562848251343427.","journal-title":"Therap Adv Gastroenterol"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.017"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000226"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14810"},{"issue":"10","key":"e_1_3_5_33_2","first-page":"733","article-title":"Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient","volume":"113","author":"Salmon Olavarria P","year":"2021","unstructured":"Salmon Olavarria P, Rubio Iturria S, Nantes Castillejo O. Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient. Rev Esp Enferm Dig 2021; 113(10): 733\u2013734.","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108517"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz015"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.047"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15963"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.10.027"},{"key":"e_1_3_5_39_2","article-title":"Tofacitinib for the treatment of ulcerative colitis, alopecia universalis, and atopic dermatitis: one drug, three diseases","volume":"27","author":"Honap S","year":"2020","unstructured":"Honap S, Cookson H, Sharma E, et al. Tofacitinib for the treatment of ulcerative colitis, alopecia universalis, and atopic dermatitis: one drug, three diseases. Inflamm Bowel Dis 2020; 27: e13\u2013e14.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000711212.36285.25"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.01.014"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae190.0765"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(20)31809-6"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0031-x"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131730"},{"issue":"8","key":"e_1_3_5_46_2","article-title":"Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn\u2019s disease","volume":"158","author":"Sandborn WJ","year":"2020","unstructured":"Sandborn WJ, Feagan BG, Loftus EVJr, et al. Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn\u2019s disease. Gastroenterology 2020; 158(8): 2123\u20132138.e8.","journal-title":"Gastroenterology"},{"issue":"8","key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41575-023-00812-0","article-title":"Upadacitinib therapy for Crohn\u2019s disease","volume":"20","author":"Kotsiliti E.","year":"2023","unstructured":"Kotsiliti E. Upadacitinib therapy for Crohn\u2019s disease. Nat Rev Gastroenterol Hepatol 2023; 20(8): 483.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413449"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00581-5"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab232.032"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19377"},{"key":"e_1_3_5_52_2","article-title":"Successful treatment of concomitant alopecia universalis and Crohn\u2019s disease with upadacitinib: a case report","volume":"11","author":"Johnston LA","year":"2023","unstructured":"Johnston LA, Lu C, Poelman SM. Successful treatment of concomitant alopecia universalis and Crohn\u2019s disease with upadacitinib: a case report. SAGE Open Med Case Rep 2023; 11: 2050313X231160914.","journal-title":"SAGE Open Med Case Rep"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001442"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.03.016"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr5005"},{"key":"e_1_3_5_56_2","first-page":"401","article-title":"Treatment of genital Crohn\u2019s disease with upadacitinib in a male child: a case report","volume":"19","author":"Bousvaros A","year":"2023","unstructured":"Bousvaros A, Schmidt B, Kurtz M. Treatment of genital Crohn\u2019s disease with upadacitinib in a male child: a case report. Gastroenterol Hepatol 2023; 19: 401\u2013403.","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15759"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219213"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235660"},{"issue":"6","key":"e_1_3_5_60_2","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf080","article-title":"Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn\u2019s disease and ulcerative colitis","volume":"19","author":"D\u2019Haens G","year":"2025","unstructured":"D\u2019Haens G, Danese S, Panaccione R, et al. Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn\u2019s disease and ulcerative colitis. J Crohns Colitis 2025; 19(6): jjaf080.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy085"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2214728"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000429"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae002"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003668"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab024"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14534"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09114"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150636"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.188"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0285-8"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30949-8"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1159\/000519320"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646680"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad061"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa359"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1741-8104"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2324400"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead448"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06415-5"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082197"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2455536"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251393391","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848251393391","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251393391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:34:33Z","timestamp":1763386473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848251393391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":81,"alternative-id":["10.1177\/17562848251393391"],"URL":"https:\/\/doi.org\/10.1177\/17562848251393391","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"type":"print","value":"1756-2848"},{"type":"electronic","value":"1756-2848"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"17562848251393391"}}